Connect with us

Business

Are All Hallucinogens Psychedelics and Are All Psychedelics Hallucinogens?

Published

on

Are all psychedelics hallucinogens and vice versa?

We are experiencing a period of change where previously prohibited and stigmatized substances are receiving favorable attention from the public. From ketamine to cannabis to magic mushrooms, the discourse has shifted from prohibition to determining the optimal ways to utilize these substances.  Our write up on the Bengzina Psychedelics show from Miami this year is a hot take, so check it out here.

However, it can be perplexing to differentiate between the terminologies, especially in psychedelics. For many, the question that needs an answer is every psychedelic a hallucinogen, and are all hallucinogens psychedelics? Keep reading to learn more.

Why Simplify Terminologies?

Before we delve into the nuances that differentiate “psychedelics” from “hallucinogens,” let’s ponder how ideas and terminologies often undergo simplification or distortion due to misunderstandings. Let’s face it, we’re not all experts in every field. When a news item gains widespread attention, it is often simplified to ensure that the general public can comprehend it, even if this means diluting or slightly altering its original definition.

Hallucinogens and Psychedelics

As we have already established, simplifying ideas and confusing terms is a common practice to make concepts more accessible to a non-expert public. This notion raises the question of whether all hallucinogens can be regarded as psychedelics, especially in this modern era of drug acceptance. The term “psychedelics” is often attributed with meanings surpassing its definition.

Consider ketamine, which has gained significant prominence with the increasing popularity of psychedelic therapy. However, ketamine is not a psychedelic despite being referred to as one, even on websites offering ketamine services. This misnomer is not intended to be misleading but to simplify the language for better understanding without overwhelming the audience with complex categorical terms. In truth, ketamine is a dissociative hallucinogen.

Psychedelics are a class of psychoactive substances known for producing profound changes in consciousness, perception, and mood. These substances alter an individual’s sensory experiences, often inducing visual and auditory hallucinations, changes in time perception, and a sense of self-transcendence or ego dissolution. The term “psychedelic” was first coined in the 1950s by British psychiatrist Humphry Osmond, who used it to describe the mind-altering effects of certain substances.

“Psychedelics” exclusively refers to four compounds: DMT, psilocybin, mescaline, and LSD. Although they each have distinct modes of action, they share the common feature of being agonists at serotonin receptors, specifically 5-HT2A. This classification is based on their method of action. On the other hand, is ketamine a serotonergic drug? No, it isn’t. Dissociative hallucinogens, such as DXM and PCP, primarily affect dopamine and NMDA receptors, albeit with their unique actions.

The classification of ketamine as a hallucinogen is evident in its class name. This illustrates that ketamine can be categorized as a hallucinogen without being psychedelic, indicating that not all hallucinogens fall under the classification of psychedelics. In fact, the four compounds recognized as psychedelics are often referred to as “classical psychedelics,” a term coined to reclassify them in the face of growing confusion regarding the true meaning of psychedelic drugs.

What Are Hallucinogens?

Hallucinogens encompass various types of drugs that share the ability to induce an altered state of mind. Significant shifts in mood, thought, and perception of one’s surroundings and self are examples. After all, a hallucination is an experience of something false or altered in our perception. This can include sensing or tasting something that isn’t there or experiencing something otherwise as it ought to be.

The effects of hallucinogens can vary widely depending on the individual, the substance, and the dosage. Some users report euphoria, enhanced creativity, and spiritual experiences, while others may experience anxiety, paranoia, and other adverse psychological effects. In some cases, hallucinogen use can lead to a phenomenon known as a “bad trip,” in which the user experiences intense anxiety, confusion, or paranoia.

The classification structure generally divides hallucinogens into three types: psychedelics (DMT, LSD, psilocybin, mescaline), dissociatives (ketamine, DXM, PCP), and deliriants (datura, Benadryl). The final group significantly affects the neurotransmitter acetylcholine, distinguishing its mode of action from the other two groups.

The classification of hallucinogens is not a neat and tidy affair, and plenty of substances fall outside the standard groupings. For instance, take Amanita muscaria mushrooms. While classified as poisonous mushrooms, they can produce potent hallucinations and interact with GABA receptors. Additionally, substances like MDMA and 2C-B are often lumped in with psychedelics, but they belong to psychostimulants and phenethylamines, respectively. Despite this, they can still induce hallucinations.

And then there’s salvia, a member of the Lamiaceae mint family with no taxonomic classification for its hallucinogenic properties. Salvia is the only known diterpene hallucinogen, making it a distinctive member of the hallucinogen family. It shares some structural similarities with cannabis components but differs dramatically from them. Given that it doesn’t target the 5-HT2A receptors, often linked to traditional psychedelics, its mode of action is still relatively mysterious. Instead, it appears to engage D2 (dopamine) receptors and -opioid receptors. Despite having hallucinatory properties, it is not psychedelic.

One inference we can draw from this is that although not all hallucinogens fall under the category of psychedelics, all psychedelics are indeed hallucinogens, along with many other non-psychedelic drugs. The term “hallucinogens” encompasses a wide range of psychoactive substances that can induce altered states of perception, regardless of their specific chemical structure or mode of action.

Conclusion

The world of hallucinogens is complex and diverse, with many different substances and classifications. While the term “psychedelic” is often used interchangeably with “hallucinogen,” it’s essential to recognize that not all hallucinogens are psychedelics, and not all psychedelics are hallucinogens. The classical psychedelics, which include DMT, psilocybin, mescaline, and LSD, are characterized by their action on serotonin receptors, specifically 5-HT2A.

Other classes of hallucinogens include dissociatives, such as ketamine, DXM, and PCP, which primarily act on dopamine and NMDA receptors. Deliriants, such as Datura and Benadryl, significantly impact the neurotransmitter acetylcholine. Other substances, like salvia and Amanita muscaria mushrooms, also produce hallucinogenic effects but don’t fit neatly into any category.

It’s worth noting that while the effects of hallucinogens can be profound and life-changing for some, they can also be unpredictable and potentially dangerous. Proper education, preparation, and harm reduction measures are crucial for anyone considering these substances.

Source: https://cannabis.net/blog/opinion/are-all-hallucinogens-psychedelics-and-are-all-psychedelics-hallucinogens

Business

Alleged Crores Pharma Scam Mastermind Arrested from Surat

Published

on

By

After evading law enforcement for nearly 13 years, an accused linked to a large-scale pharmaceutical fraud case has been arrested by Delhi Police from Surat, Gujarat. The suspect is alleged to have orchestrated a series of financial scams involving fake identities, forged documents, and dishonoured cheques used to procure high-value pharmaceutical raw materials.

Authorities say the accused, identified as Himmat Singh Lodha, is believed to have defrauded multiple pharmaceutical companies in Delhi of goods worth approximately ₹98 lakh before disappearing and remaining underground for years.

Fake Business Deals and Dishonoured Cheques Used in Fraud

Investigators claim the accused posed as a legitimate pharmaceutical trader and placed bulk orders for expensive drug ingredients, offering post-dated cheques as payment security.

In one documented case from 2013, he allegedly obtained around 550 kilograms of Gliclazide, a diabetes-related pharmaceutical ingredient, valued at over ₹26 lakh. When suppliers attempted to encash the cheques, they were reportedly returned with the remark “account closed.”

Following the transaction, the accused allegedly vacated his office and rented residence and disappeared without settling payments. He was later declared a proclaimed offender in 2016 after repeatedly failing to appear before court proceedings. Authorities had also issued a reward for information leading to his arrest.

Multiple Identities and Repeated Fraud Pattern

Police investigations further link the accused to another cheating case dating back to 2012, where he allegedly used a fake identity, “Kailash Jain,” to obtain a large consignment of Ambroxol HCL, a pharmaceutical compound used in cough medications. The value of that consignment was estimated at around ₹72 lakh.

Officials believe the accused followed a consistent modus operandi—posing as a credible businessman, securing high-value goods on deferred payment terms, and then disappearing after delivery while shutting down business operations.

Investigators suspect that forged business records, fake company credentials, and fabricated financial histories were used to build trust with suppliers and gain access to expensive raw materials.

Multi-State Surveillance Leads to Arrest in Surat

A special Crime Branch team tracked the accused through coordinated surveillance efforts across multiple cities, including Mumbai, Ahmedabad, and Surat. After nearly a month of technical monitoring and intelligence gathering, officials located and arrested him from a residential area in Surat.

Authorities also revealed that the accused had been involved in property-related activities while staying under the radar to avoid detection.

Growing Threat of Corporate Identity Fraud

The case highlights a rising trend of organised financial fraud targeting industries that rely heavily on trust-based transactions and deferred payments. Experts note that criminals increasingly exploit gaps in corporate verification systems by using fake GST registrations, temporary offices, and forged documentation to appear legitimate.

Cybercrime and financial fraud specialists warn that such schemes are becoming more complex with the widespread availability of digital business tools, making it easier to create convincing but fraudulent corporate identities.

Experts Urge Stronger Due Diligence in High-Value Transactions

Experts, including former IPS officer and cybercrime specialist Prof. Triveni Singh, emphasize the need for stricter verification procedures in commercial dealings. He noted that relying solely on paperwork or digital business profiles can expose companies to significant financial risk.

Authorities and industry experts recommend physical verification of business operations, bank account validation, and detailed background checks before engaging in high-value or deferred-payment transactions—particularly in sectors like pharmaceuticals, where single consignments can involve transactions worth crores.

Continue Reading

Business

EU Pressure Builds on Google as Regulators Face Calls for Massive Fine Over Search Practices

Published

on

By

A growing coalition of European industry groups is intensifying pressure on regulators to take decisive action against Google over allegations of unfair search practices that could reshape competition rules across the region’s digital economy.

Investigation Under Digital Markets Act Gains Momentum

The case is being examined by the European Commission under the European Union’s landmark Digital Markets Act (DMA), introduced to curb the dominance of major technology platforms and ensure fair competition.

Launched in March 2024, the investigation focuses on whether Google has been prioritising its own services in search results, potentially disadvantaging rival businesses that rely on online visibility to reach customers.

Industry Groups Demand Swift Action

Several prominent European organizations have jointly urged regulators to conclude the probe without further delay. They argue that prolonged investigations allow alleged anti-competitive practices to continue, putting European companies—especially startups—at a disadvantage.

Signatories include the European Publishers Council, the European Magazine Media Association, the European Tech Alliance, and EU Travel Tech.

In a joint statement, these groups warned that delays in enforcement are affecting innovation, profitability, and growth prospects for regional businesses competing in digital markets.

Google Denies Allegations

Google has rejected claims of bias, stating that its search algorithms are designed to deliver the most relevant and useful results to users. The company has also proposed adjustments to address regulatory concerns.

However, critics argue that these changes are insufficient and fail to address the core issue of market dominance.

Potential Billion-Euro Penalties

If found in violation of the DMA, Google could face significant financial penalties. Under EU rules, fines can reach a substantial percentage of a company’s global turnover, potentially amounting to billions of euros.

Regulators may also impose corrective measures requiring changes to business practices, which could have long-term implications for how digital platforms operate in Europe.

Wider Implications for Big Tech

The case highlights ongoing tensions between European regulators and major U.S. technology firms. In recent years, the EU has taken a more aggressive stance in enforcing competition laws, aiming to create a level playing field for local businesses.

A final ruling against Google could set a major precedent, influencing future enforcement actions and shaping the regulatory landscape for global tech companies operating within Europe.

As scrutiny intensifies, the outcome of the investigation is expected to play a critical role in defining the future of digital competition across the European Union.

Continue Reading

AI & Technology

Amazon Faces Potential Criminal Trial in Italy Over €1.2 Billion Tax Evasion Allegations

Published

on

By

Milan: U.S. tech giant Amazon is facing the prospect of a major legal showdown in Italy, after prosecutors in Milan formally requested a court to move forward with criminal proceedings over alleged tax evasion totaling approximately ₹12,500 crore (€1.2 billion).

The case targets Amazon’s European division along with four senior executives, marking one of the most significant tax-related investigations involving a global e-commerce platform in Europe.

Trial Push Despite Multi-Million Euro Settlement

The move comes even after Amazon reached a financial settlement with Italian tax authorities in December, agreeing to pay around ₹5,500 crore (€527 million), including interest, to resolve part of the dispute.

Typically, such settlements lead to the closure of criminal investigations. However, Milan prosecutors have opted to proceed, signaling a tougher stance on alleged corporate tax violations.

A preliminary hearing is expected in the coming months, where a judge will decide whether to formally indict the company and its executives or dismiss the case.

Allegations of VAT Evasion Through Marketplace Sellers

At the center of the investigation are claims that Amazon’s platform enabled non-European Union sellers to avoid paying value-added tax (VAT) on goods sold to Italian consumers between 2019 and 2021.

Prosecutors allege that the company’s marketplace structure allowed thousands of foreign vendors—many reportedly based in China—to operate without fully disclosing their identities or tax obligations. This, authorities argue, led to substantial VAT losses for the Italian government.

Under Italian law, online platforms facilitating sales can be held partially liable if third-party sellers fail to comply with tax requirements, a key point in the prosecution’s case.

Italian Government Named as Affected Party

In their filing, prosecutors identified Italy’s Economy Ministry as the injured party, citing significant financial damage resulting from the alleged tax evasion.

Legal experts say the outcome of the case could have wide-ranging implications across the European Union, where VAT systems are harmonized and similar compliance rules apply to digital marketplaces.

Multiple Investigations Add to Pressure

The VAT probe is just one of several legal challenges facing Amazon in Italy. The European Public Prosecutor’s Office is reportedly examining additional tax-related issues covering more recent years.

Meanwhile, Milan authorities are pursuing separate investigations into alleged customs fraud linked to imports from China and whether Amazon maintained an undeclared “permanent establishment” in Italy—potentially exposing it to higher tax liabilities.

In a separate regulatory action, Italy’s data protection authority recently ordered an Amazon unit to stop using personal data from over 1,800 employees at a warehouse near Rome.

Amazon Denies Allegations

Amazon has consistently denied wrongdoing and indicated it will strongly contest the allegations in court if the case proceeds. The company has also warned that prolonged legal uncertainty could impact investor confidence and Italy’s appeal as a destination for international business.

Broader Impact on Europe’s Digital Economy

If the case moves to trial, it could become a landmark moment for the regulation of global e-commerce platforms in Europe. Governments across the region are increasingly scrutinizing how digital marketplaces handle tax compliance, especially in cross-border transactions.

With online retail continuing to expand, regulators are under mounting pressure to ensure that multinational platforms and third-party sellers adhere to the same tax rules as traditional businesses.

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News